Scientists discover a ‘promising’ breast cancer relapse detection breakthrough

Tissue samples from 1,178 women with the most common form of breast cancer were used in the experiment. The likelihood of tumours flaring up again within five years was 23 per cent higher in women with the immune cell 'hotspots'

 

Scientists discover a ‘promising’ breast cancer relapse detection breakthrough

Researchers have found a way to potentially identify women at risk of relapsing breast cancer.

Patients with high numbers of immune cell ‘hotspots’ around tumours were 25 per cent more likely to see the cancer return within a decade, indicates a study.

The likelihood of tumours flaring up again within five years was 23 per cent higher in women with the hotspots.

Those whose immune cells were evenly dispersed held a better chance of fending off cancer for good.

Researchers have found a way to potentially identify women at risk of relapsing breast cancer.

Patients with high numbers of immune cell ‘hotspots’ around tumours were 25 per cent more likely to see the cancer return within a decade, indicates a study.

The likelihood of tumours flaring up again within five years was 23 per cent higher in women with the hotspots.

Those whose immune cells were evenly dispersed hold a better chance of fending off cancer for good.

Dr Yinyin Yuan, from The Institute of Cancer Research in London, said her team had developed a new, automated computer tool that spatially measures tumours.

While larger studies are needed before the technology can be rolled out in clinics, Dr Yuan said, “In future such a test could pick out patients at the highest risk of their cancer returning.”

The findings of this study appear in the Journal of the National Cancer Institute.

Katherine Woods, from the charity Breast Cancer Now, which co-funded the study, said the ‘exciting’ tool would be very promising at detecting women with a high chance of breast cancer relapse”.

She added, “Automatically analysing the distribution of immune cells in a tumour is a big achievement, and if this approach is validated it could help doctors guide chemotherapy treatment.”

Tissue samples from 1,178 women with the most common form of breast cancer were used in the experiment.

Source: SkyNews